BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28003583)

  • 1. Optimizing an ion semiconductor sequencing data analysis method to identify somatic mutations in the genomes of cancer cells in clinical tissue samples.
    Nagashima T; Shimoda Y; Tanabe T; Naruoka A; Saito J; Serizawa M; Ohshima K; Urakami K; Ohnami S; Ohnami S; Mochizuki T; Kusuhara M; Yamaguchi K
    Biomed Res; 2016; 37(6):359-366. PubMed ID: 28003583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.
    Shimoda Y; Nagashima T; Urakami K; Tanabe T; Saito J; Naruoka A; Serizawa M; Mochizuki T; Ohshima K; Ohnami S; Ohnami S; Kusuhara M; Yamaguchi K
    Biomed Res; 2016; 37(6):367-379. PubMed ID: 28003584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis in cancer exome sequencing.
    Evans P; Kong Y; Krauthammer M
    Methods Mol Biol; 2014; 1176():219-27. PubMed ID: 25030931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized genomic analyses for cancer mutation discovery and interpretation.
    Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
    Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.
    Vanni I; Coco S; Truini A; Rusmini M; Dal Bello MG; Alama A; Banelli B; Mora M; Rijavec E; Barletta G; Genova C; Biello F; Maggioni C; Grossi F
    Int J Mol Sci; 2015 Dec; 16(12):28765-82. PubMed ID: 26633390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.
    Garofoli A; Paradiso V; Montazeri H; Jermann PM; Roma G; Tornillo L; Terracciano LM; Piscuoglio S; Ng CKY
    J Mol Diagn; 2019 Sep; 21(5):884-894. PubMed ID: 31229654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data.
    do Valle ÍF; Giampieri E; Simonetti G; Padella A; Manfrini M; Ferrari A; Papayannidis C; Zironi I; Garonzi M; Bernardi S; Delledonne M; Martinelli G; Remondini D; Castellani G
    BMC Bioinformatics; 2016 Nov; 17(Suppl 12):341. PubMed ID: 28185561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RareVar: A Framework for Detecting Low-Frequency Single-Nucleotide Variants.
    Hao Y; Xuei X; Li L; Nakshatri H; Edenberg HJ; Liu Y
    J Comput Biol; 2017 Jul; 24(7):637-646. PubMed ID: 28541743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
    Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.
    Lee HB; Joung JG; Kim J; Lee KM; Ryu HS; Lee HO; Moon HG; Park WY; Noh DY; Han W
    Cancer Cytopathol; 2015 Nov; 123(11):669-77. PubMed ID: 26265110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of pathogenic mutations in Marfan syndrome by targeted next-generation semiconductor sequencing].
    Lu C; Wu W; Xiao J; Meng Y; Zhang S; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Jun; 30(3):301-4. PubMed ID: 23744319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing.
    Spinella JF; Mehanna P; Vidal R; Saillour V; Cassart P; Richer C; Ouimet M; Healy J; Sinnett D
    BMC Genomics; 2016 Nov; 17(1):912. PubMed ID: 27842494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a combinatorial pipeline using two somatic variant  calling  methods  for whole exome sequence data of gastric cancer.
    Kohmoto T; Masuda K; Naruto T; Tange S; Shoda K; Hamada J; Saito M; Ichikawa D; Tajima A; Otsuji E; Imoto I
    J Med Invest; 2017; 64(3.4):233-240. PubMed ID: 28954988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and clinical application of an integrative genomic approach to personalized cancer therapy.
    Uzilov AV; Ding W; Fink MY; Antipin Y; Brohl AS; Davis C; Lau CY; Pandya C; Shah H; Kasai Y; Powell J; Micchelli M; Castellanos R; Zhang Z; Linderman M; Kinoshita Y; Zweig M; Raustad K; Cheung K; Castillo D; Wooten M; Bourzgui I; Newman LC; Deikus G; Mathew B; Zhu J; Glicksberg BS; Moe AS; Liao J; Edelmann L; Dudley JT; Maki RG; Kasarskis A; Holcombe RF; Mahajan M; Hao K; Reva B; Longtine J; Starcevic D; Sebra R; Donovan MJ; Li S; Schadt EE; Chen R
    Genome Med; 2016 Jun; 8(1):62. PubMed ID: 27245685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying cancer genomics through next-generation DNA sequencing and bioinformatics.
    Doyle MA; Li J; Doig K; Fellowes A; Wong SQ
    Methods Mol Biol; 2014; 1168():83-98. PubMed ID: 24870132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of variations and identifying genomic breakpoints for large deletions in the LDLR by Ion Torrent semiconductor sequencing.
    Faiz F; Allcock RJ; Hooper AJ; van Bockxmeer FM
    Atherosclerosis; 2013 Oct; 230(2):249-55. PubMed ID: 24075752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.